We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+1.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.54B
AUM Growth
-$175M
(-2.3%)
Cap. Flow
-$162M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.97%
Holding
2,467
New
22
Increased
509
Reduced
1,757
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$26.2M |
| 2 |
Microsoft
MSFT
|
+$22.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$17.2M |
| 4 |
Meta Platforms (Facebook)
META
|
+$11.3M |
| 5 |
Intel
INTC
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$8.87M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$7.51M |
| 3 |
Wells Fargo
WFC
|
+$6.77M |
| 4 |
JPMorgan Chase
JPM
|
+$6.34M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$5.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Financials | 16.41% |
| 3 | Healthcare | 13.76% |
| 4 | Industrials | 8.56% |
| 5 | Consumer Discretionary | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Nektar Therapeutics
NKTR
$2.39B
| $1.4M | 0.02% |
7,719
-1,850
| -19% | -$354K |
|
927
MarketAxess Holdings
MKTX
$4.15B
| $1.39M | 0.02% |
22,510
+2,621
| +13% | +$148K |
|
928
Encompass Health
EHC
$11.2B
| $1.39M | 0.02% |
47,386
-10,692
| -18% | -$326K |
|
|
EQC
929
DELISTED
Equity Commonwealth
EQC
| $1.39M | 0.02% |
53,928
-2,666
| -5% | -$71K |
|
930
Mine Safety
MSA
$6.74B
| $1.38M | 0.02% |
27,916
-972
| -3% | -$53.8K |
|
|
FCE.A
931
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $1.37M | 0.02% |
70,237
-10,044
| -13% | -$201K |
|
|
AUXL
932
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $1.37M | 0.02% |
45,908
-9,098
| -17% | -$193K |
|
|
ELME
933
Elme Communities
ELME
$132M
| $1.37M | 0.02% |
53,905
-11,732
| -18% | -$313K |
|
|
PLL
934
DELISTED
PALL CORP
PLL
| $1.37M | 0.02% |
16,345
-1,864
| -10% | -$153K |
|
935
Curtiss-Wright
CW
$27.7B
| $1.36M | 0.02% |
20,670
-5,172
| -20% | -$348K |
|
|
MDCO
936
DELISTED
Medicines Co
MDCO
| $1.36M | 0.02% |
61,031
-12,691
| -17% | -$322K |
|
937
Fidelity National Financial
FNF
$13.9B
| $1.36M | 0.02% |
70,683
-239,675
| -77% | -$4.64M |
|
938
New York Times
NYT
$11.6B
| $1.36M | 0.02% |
121,315
-2,143
| -2% | -$27.7K |
|
|
EQY
939
DELISTED
Equity One
EQY
| $1.36M | 0.02% |
62,941
+5,293
| +9% | +$123K |
|
940
Telephone and Data Systems
TDS
$3.91B
| $1.36M | 0.02% |
56,645
+4,783
| +9% | +$121K |
|
|
SNI
941
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $1.36M | 0.02% |
17,376
-1,235
| -7% | -$99.5K |
|
942
John Wiley & Sons Class A
WLY
$2.52B
| $1.35M | 0.02% |
24,134
+2,842
| +13% | +$169K |
|
943
GATX Corp
GATX
$6.55B
| $1.35M | 0.02% |
23,175
+1,944
| +9% | +$126K |
|
|
ADVS
944
DELISTED
Advent Software Inc
ADVS
| $1.35M | 0.02% |
42,857
-247
| -0.6% | -$7.95K |
|
|
DBD
945
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.35M | 0.02% |
38,215
+3,882
| +11% | +$146K |
|
946
Pitney Bowes
PBI
$2.42B
| $1.34M | 0.02% |
53,803
-772
| -1% | -$20.6K |
|
947
Ball Corp
BALL
$17B
| $1.34M | 0.02% |
42,338
-3,950
| -9% | -$126K |
|
948
Post Holdings
POST
$4.12B
| $1.34M | 0.02% |
61,643
-1,013
| -2% | -$27K |
|
|
CAVM
949
DELISTED
Cavium, Inc.
CAVM
| $1.34M | 0.02% |
26,902
-3,598
| -12% | -$182K |
|
950
Tyler Technologies
TYL
$12.2B
| $1.34M | 0.02% |
15,125
-3,245
| -18% | -$293K |
|
Similar funds
ProShare Advisors's Q3 2014 Portfolio in Review
As of Q3 2014, ProShare Advisors held 2,467 positions worth $7.54B, down 2.3% from $7.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors's Q3 2014 filing shows 22 new, 509 increased, 1,757 reduced and 175 closed positions. Its largest new stake was Discovery, Inc. Series C Common Stock: 80,042 shares worth $2.98M. The largest sale was ExxonMobil, an estimated $8.87M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- ProShare Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 80,042 shares worth $2.98M.
- ProShare Advisors added most to Apple in Q3 2014, an estimated $26.2M increase.
- ProShare Advisors's biggest Q3 2014 reduction was ExxonMobil, cutting an estimated $8.87M.
- ProShare Advisors fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $5.81M.
- ProShare Advisors's ten largest holdings make up 16% of its $7.54B portfolio in Q3 2014.
- ProShare Advisors opened 22 new positions and closed 175 in Q3 2014.
- ProShare Advisors's portfolio value fell 2.3% quarter-over-quarter to $7.54B.
Based on ProShare Advisors's 13F filing for Q3 2014, filed 6 Nov 2014.